Search for drugs:
Typing the drug name to query
MIGALASTAT HYDROCHLORIDE
DIR Classification
Classification:Ambiguous
Severity Score:1.0
Description in Drug Labeling: View Full Labeling: SPL in DailyMed | PDF
- CLINICAL PHARMACOLOGY
- Pharmacodynamics
- Cardiac Electrophysiology
- At a dose approximately 8 times the recommended dose, GALAFOLD did not prolong the QT interval to any clinically relevant extent.
Postmarketing Surveillance
Contingency Table:
Current Drug
Other Drugs
QT Prolongation
0
24092
Other ADRs
557
38381030
Odds Ratio = 0.0
Drug Property Information
ATC Code(s):
- A16AX14 - migalastat hydrochloride
- A16AX - Various alimentary tract and metabolism products
- A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
- A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
- A - ALIMENTARY TRACT AND METABOLISM
Active Ingredient:MIGALASTAT HYDROCHLORIDE
Active Ingredient UNII:CLY7M0XD20
Drugbank ID:DB05018
PubChem Compound:176077
CTD ID: C090092
CAS Number:108147-54-2
Dosage Form(s):capsule
Route(s) Of Administrator:oral
Daily Dose:
- 61.5 mg/day A16AX14
Chemical Structure: 
SMILE Code:
OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
Reference
N/A
Disclaimer:
The content of this database of QT prolongation is intended for educational and scientific research purposes only. It is not intended as a substitute for professional medical advice, diagnosis or treatment.
Any mention of commercial products is for clarification and not intended as endorsement.